Imre Kacskovics | |
---|---|
Born | 23 September 1961 |
Nationality | Hungarian |
Citizenship | Hungarian |
Occupation | academic |
Academic background | |
Education | Eötvös Loránd University |
Alma mater | University of Veterinary Medicine Budapest Budapest University of Technology and Economics Eötvös Loránd University |
Academic work | |
Discipline | Immunology |
Institutions | Eötvös Loránd University |
Imre Kacskovics (23 September 1961, Budapest) is a Hungarian immunologist and the current dean of the Faculty of Science of the Eötvös Loránd University.[1][2]
He was born in 1961 in Budapest and he has been married with 3 children.
He obtained a degree in veterinary in 1987 from the University of Veterinary Medicine Budapest. In 1991, he obtained a degree in nuclear technology and radiation from the Budapest University of Technology and Economics. In 1998, he obtained a Doctor of Philosophy from the University of Veterinary Medicine Budapest.[3] His thesis was entitled The examination of the VH and CH immunoglobin genes of the pigs (in Hungarian: A sertés VH és CH immunglobulin génjeinek vizsgálata).
In 1999, he was a Visiting scholar at the Brandeis University, Massachusetts, United States.[4]
In 2019, he was appointed as the Dean of the ELTE Faculty of Science.[5]
During the COVID-19 pandemic in Hungary, he worked as a consultant for Hungarian prime minister Viktor Orbán.[6][7] He was interviewed several times during the pandemic.[8][9] In 2020, he was interviewed by Politico.[10]
He was appointed as the Head of the Drug Development Consortium working under the auspices of the Ministry of Innovation and Technology.[11] In October 2021, he said that the Hungarian COVID drug might be tested on animals in 2023.[12]
On 13 September 2022, he delivered a speech at the MLE Citizen Science working group meeting in Budapest.[13]
B Dudok, L Barna, M Ledri, SI Szabó, E Szabadits, B Pintér (2015). Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature neuroscience, 18(1), 75–86.[15]
C Fekete, B Gereben, M Doleschall, JW Harney, JM Dora, AC Bianco (2004). Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology, 145(4), 1649–1655.[16]